Gallium trinitrate hydrate
Gallium trinitrate hydrate structure
|
Common Name | Gallium trinitrate hydrate | ||
|---|---|---|---|---|
| CAS Number | 69365-72-6 | Molecular Weight | 276.77700 | |
| Density | N/A | Boiling Point | 83ºC at 760 mmHg | |
| Molecular Formula | GaH5N3O10 | Melting Point | 110 °C (dec.)(lit.) | |
| MSDS | Chinese USA | Flash Point | N/A | |
| Symbol |
GHS03, GHS07 |
Signal Word | Danger | |
| Name | Gallium(III) nitrate hydrate |
|---|---|
| Synonym | More Synonyms |
| Boiling Point | 83ºC at 760 mmHg |
|---|---|
| Melting Point | 110 °C (dec.)(lit.) |
| Molecular Formula | GaH5N3O10 |
| Molecular Weight | 276.77700 |
| Exact Mass | 275.92300 |
| PSA | 215.87000 |
| LogP | 0.74470 |
| Stability | Stable. Oxidizer - contact with combustible material may lead to fire. Incompatible with reducing agents, combustible material. |
| Symbol |
GHS03, GHS07 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H272-H315-H319-H335 |
| Precautionary Statements | P220-P261-P305 + P351 + P338 |
| Personal Protective Equipment | Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
| Hazard Codes | O,Xi |
| Risk Phrases | 8-36/37/38 |
| Safety Phrases | S17-S26-S36/37/39 |
| RIDADR | UN 1477 5.1/PG 3 |
| WGK Germany | 3 |
| RTECS | LW9625000 |
| Packaging Group | III |
| Hazard Class | 5.1 |
|
Design and properties of novel gallium-doped injectable apatitic cements.
Acta Biomater. 24 , 322-32, (2015) Different possible options were investigated to combine an apatitic calcium phosphate cement with gallium ions, known as bone resorption inhibitors. Gallium can be either chemisorbed onto calcium-defi... |
|
|
Gallium nitrate: the second metal with clinical activity.
Cancer Treat. Rep. 70(11) , 1311-9, (1986) Gallium nitrate is the anhydrate salt of the naturally occurring heavy metal. It has demonstrated antitumor activity in a variety of murine tumor models, including Walker carcinosarcoma 256, fibrosarc... |
|
|
Gallium nitrate for the treatment of bone metastases.
Cancer 80(S8) , 1680-1685, (1997) Gallium nitrate was originally developed as an antineoplastic agent; however, further studies have revealed that this drug has extremely potent effects on turnover of bone, and that low doses can be u... |
| gallium,trinitrate,hydrate |
| MFCD00149723 |
| EINECS 236-815-5 |
| Gallium trinitrate hydrate |